HT1080 Human Fibrosarcoma Cells Selected for Super-eribulin Resistance In Vitro Become More Malignant and Are Arrested Synergistically by Methionine Restriction in Combination With Eribulin in Nude Mice Article Swipe
Related Concepts
Eribulin
HT1080
Fibrosarcoma
In vitro
Cancer research
Methionine
Chemistry
Biology
Medicine
Cancer
Biochemistry
Pathology
Internal medicine
Breast cancer
Amino acid
Metastatic breast cancer
Sei Morinaga
,
KOHEI MIZUTA
,
Byung Mo Kang
,
Qinghong Han
,
Michael Bouvet
,
Norio Yamamoto
,
Katsuhiro Hayashi
,
HIROAKI KIMURA
,
Shinji Miwa
,
Kentaro Igarashi
,
Takashi Higuchi
,
Hiroyuki Tsuchiya
,
Satoru Demura
,
Robert M. Hoffman
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21873/invivo.13931
· OA: W4409888546
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.21873/invivo.13931
· OA: W4409888546
Methionine restriction combined with eribulin represents a promising strategy to effectively treat eribulin-resistant high-malignancy fibrosarcoma, that can be immediately applied to the clinic.
Related Topics
Finding more related topics…